As shown in Supplementary Figure 1, the EYA2 expression was upregulated in both lung adenocarcinoma (p = 0.012) and lung squamous cell carcinoma (p = 0.005), which was also consistent with results from analysis of different lung cancer datasets. Here, EYA2 is linked to lung adenocarcinoma.